We achieved a 122x iPS expansion factor in a 1L bioreactor in 6 days
and demonstrated that our approach for iPS culture is GROUNDBREAKING in terms of viability, stemness, pluripotency and genomic integrity (publication submitted).
We robusted our lead cell therapy program for Parkinson’s disease
An advanced proof-of-concept study demonstrated best-in-class results, with full motor function recovery 2x faster than with progenitors. A regulatory roadmap was established with Voisin Consulting to reach a first-in-human trial in 2024.
for the QC-Stem international consortium on iPS quality launched with the Harvard Stem Cell Institute and the Dana Farber in Boston, the FBRI at Kobe, and the Imagine Institute in Paris.
with a first contract with a top-10 pharma company (undisclosed) signed in Q4, and a partnership announced with the French Blood Agency (EFS) for the mass-production of iPS-derived HSC transplants.
So we’d like to address a BIG “thank you” to everyone who supported us in 2020, as well as special thanks to the teams who made the COVID vaccines possible and available worldwide.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
